Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Embrex, Inc. (NasdaqNM:EMBX)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Recent Events
July 23Price hit new 52-week high ($18.55)
Location
1040 Swabia Court
Durham, NC 27703
Phone: (919) 941-5185
Fax: (919) 941-5186
Email: ir@embrex.com
Employees (last reported count): 198
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Consumer Non-Cyclical
 ·Industry: Fish/Livestock
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 36%
·Institutional: 31% (48% of float)
(48 institutions)
·Net Inst. Buying: 222.0K shares (+8.16%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Embrex, Inc. develops and markets biological delivery technology and biological products to increase the productivity and profitability of the global poultry industry. Embrex has developed and commercialized the Inovoject system, a proprietary, automated in-the-egg injection system that can inoculate 20,000 to 50,000 eggs per hour and eliminates the need for manual, post-hatch injection of certain vaccines. In addition to the Inovoject system, Embrex has developed and is marketing its Viral Neutralizing Factor (VNF) technology, useful in the development of certain avian vaccines. The Company also has developed and is marketing Bursaplex, a VNF-based vaccine for protection against avian infectious bursal disease (IBD). Embrex also is developing various other proprietary pharmaceutical and biological products to improve bird health, reduce bird production costs and provide other economic benefits to the poultry industry.
More from Market Guide: Expanded Business Description

Financial Summary
Embrex, Inc. develops and markets biological delivery technology and biological products to increase the productivity and profitability of the global poultry industry. For the six months ended 6/30/01, revenues rose 14% to $21.6 million. Net income rose 26% to $4 million. Revenues reflect additional installations of Inovoject(R) systems and increased injection activity. Higher income also reflects a change in product mix and higher operating efficiencies.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Peter Holzer, 55
Chairman
--  --  
Randall Marcuson, 52
Pres, CEO and Directtor
$410K$473K
Don Seaquist, 52
VP of Fin. and Admin.
245K--  
Brian Cosgriff, 48
VP of Sales and Marketing
230K197K
David Baines, Ph.D., 53
VP of Global Marketing and Sales
214K--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:EMBXAs of 31-Aug-2001
Price and Volume
52-Week Low
on 27-Mar-2001
$11.063
Recent Price$16.70 
52-Week High
on 23-July-2001
$18.55 
Beta0.30 
Daily Volume (3-month avg)33.5K
Daily Volume (10-day avg)28.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+28.5%
52-Week Change
relative to S&P500
+72.3%
Share-Related Items
Market Capitalization$135.8M
Shares Outstanding8.13M
Float5.20M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$3.44 
Earnings (ttm)$0.87 
Earnings (mrq)$0.22 
Sales (ttm)$4.82 
Cash (mrq)$0.72 
Valuation Ratios
Price/Book (mrq)4.86 
Price/Earnings (ttm)19.24 
Price/Sales (ttm)3.47 
Income Statements
Sales (ttm)$41.4M
EBITDA (ttm)$12.1M
Income available to common (ttm)$7.46M
Profitability
Profit Margin (ttm)18.0%
Operating Margin (ttm)19.0%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)27.64%
Return on Equity (ttm)32.22%
Financial Strength
Current Ratio (mrq)5.24 
Debt/Equity (mrq)0.00 
Total Cash (mrq)$5.76M
Short Interest
As of 8-Aug-2001
Shares Short1,000 
Percent of Float0.0%
Shares Short
(Prior Month)
3,000 
Short Ratio0.03 
Daily Volume35.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.